Rome Foundation Research Award
2008 Rome Foundation Research Award
The Rome Foundation established a Research Committee in January 2007, chaired by William Whitehead and Enrico Corazziari. The Research committee is responsible for developing guidelines, overseeing the process, and monitoring progress of research grants awarded by the Foundation. One or more awards of up to $50,000 will be given annually. Preference will be given to applications that (1) test the validity and/or utility of the Rome III diagnostic criteria, (2) assess the epidemiology of functional GI and motility disorders, or (3) advance knowledge of outcome assessment or trial design for FGID treatment trials. The first awardee is Dr. Madhulika Varma.
Madhulika G. Varma, MD
Principle Investigator: Madhulika G. Varma, MD
Assistant Professor
UCSF Department of Surgery
Comprehensive validation of the
Rome III constipation module
Dr. Madhulika Varma is a colon and rectal surgeon who specializes in fecal incontinence and pelvic floor disorders. She is a graduate of Brown University School of Medicine and completed her residency in general surgery at UCSF and a fellowship in colon and rectal surgery at the University of Minnesota. Her research focuses on constipation, fecal incontinence, and pelvic floor disorders.
Background: The absence of a standardized, well-validated measure of constipation severity has been a significant obstacle to research that seeks to assess treatment outcomes for constipation. Although the Rome criteria were the standard basis for identifying constipation, their inability to assess symptom severity hindered their use. The newly revised Rome Ill Constipation Module (RCM) assesses symptom severity and demonstrates excellent test-retest reliability and specificity of diagnostic criteria, but requires further validation testing. We developed the Constipation Severity Instrument (CSI), a reliable and valid sixteen-item measure that assesses constipation severity and identifies constipation subtypes. We propose to strengthen the validity of the RCM and CSI by comprehensively validating both instruments and comparing their ability to assess constipation severity.
Aims: To 1) determine convergent validity of the RCM, 2) establish criterion validity of the RCM and CSI, and 3) assess sensitivity to change validity of the RCM and CSI by using their severity scores to test the efficacy of biofeedback therapy.
Methods: We will assess convergent validity by correlating RCM subgroup and total scores to CSI subscale and total scores. We will establish criterion validity by using multiple regression analysis of RCM and CSI scores as predictor variables for the number of abnormal anorectal physiology test results, will correlate these scores to all testing results, and will determine threshold severity scores. We will determine sensitivity to change validity by using repeated measures analysis to assess the ability of the RCM and CSI scores to change after biofeedback and counseling for pelvic floor dyssynergia patients. Well-validated, standardized instruments of constipation severity will have significant ramifications on constipation assessment and measurement of treatment outcomes. The use of such instruments has the potential to influence health care providers' perspectives and behaviors, thus producing a significant impact on evaluation, treatment, and perhaps even clinical outcomes.